Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin
Streams: Advanced Therapies, Cancer
Gregory Block is Senior Vice President, Corporate Development of Notch Therapeutics. Prior to his position with Notch, he served as Director of Business Development for Astellas Pharmaceuticals, where he led business development and strategic initiatives for regenerative medicine and cell therapy immune oncology. Dr. Block joined Astellas via the company’s 2018 acquisition of Universal Cells Inc., where he was instrumental in company-building and business development. He holds a Ph.D. in Molecular Biology from Tulane University and completed a fellowship at the University of Washington.